drugset / Trial / NCT00732537

Inhaled Nitric Oxide by Oxygen Hood in Neonates

NCT00732537

Phase 4 Completed 8 enrolled University of Alabama at Birmingham
RandomizedParallel-groupTriple-blindTreatment

Summary

Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.

Timeline

Start
1999-03
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 20 ppm Inhaled
Comparator Oxygen Other / unclassified 90 % Inhaled